TAK-960 hydrochloride
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 1137868-96-2 | Cat. No. | BCP28992 |
| Name | TAK-960 hydrochloride | ||
| Synonyms | TAK960 hydrochloride; TAK 960 hydrochloride; | ||
| SMILES | O=C1C(F)(F)CN(C3CCCC3)C(N=C(NC4=CC(F)=C(C(NC5CCN(C)CC5)=O)C=C4OC)N=C2)=C2N1C.Cl | ||
| Chemical Name | |||
| Formula | C27H34F3N7O3.HCl | M. Wt | 598.06 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | TAK-960 hydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM at 10 μM ATP; also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. IC50 & Target: IC50: 0.8 nM (PLK1, + ATP), 16.9 nM (PLK2, + ATP), 50.2 nM (PLK3, + ATP)[1] In Vitro: TAK-960 inhibits full-length PLK1 protein with IC50 of 0.8 nM, wich is 20-fold lower than the next lowest IC50 value (PLK2: 16.9 nM). TAK-960 (2-1000 nM) causes accumulation of G2-M cells in HT-29 cells. TAK-960 inhibits proliferation of multiple cancer cell lines, with mean EC50 values ranging from 8.4 to 46.9 nM, but not in nondividing normal cells. TAK-960 (8 nM) leads to G2/M cell cycle arrest without significant cytotoxicity in HeLa cells. TAK-960 does not sensitize cancer cells to radiation when an insufficient amount of time is provided to induce mitotic arrest. The overexpression of a PLK1 mutant, PLK1-R136G&T210D;, which is confirmed to cancel the TAK-960-mediated increase in the proportion of mitotic cells, abrogates the radiosensitizing effects of TAK-960[2]. In Vivo: TAK-960 (7.5 mg/kg, p.o.) shows a significant increase in median survival compared with vehicle in MV4-11 human leukemia model. TAK-960 (10 mg/kg, p.o.) inhibits tumor growth in the MDR1-expressing K562ADR-bearing leukemia xenograft model. TAK-960 (10 mg/kg) significantly suppresses tumor growth when combined with IR in tumor xenografts. | ||
Recommend Products
More >
-
Onvansertib fumarate
Cat. No.：BCP49273
No.：1263293-37-3
Product Details -
TC-S 7005
Cat. No.：BCP48202
No.：1082739-92-1
Product Details -
-
ON1231320
Cat. No.：BCP40722
No.：1312471-39-8
Product Details -
-
CFI-400437
Cat. No.：BCP29569
No.：1247000-76-5
Product Details -
CFI-400945 fumarate
Cat. No.：BCP25931
No.：1616420-30-4
Product Details -
-
Mps1-in-2
Cat. No.：BCP19164
No.：1228817-38-6
Product Details -
Centrinone
Cat. No.：BCP17384
No.：1798871-30-3
Product Details -
-
SBE 13 hydrochloride
Cat. No.：BCP23836
No.：1052532-15-6
Product Details -
LFM-A13(Z)
Cat. No.：BCP12817
No.：244240-24-2
Product Details -
Onvansertib
Cat. No.：BCP28066
No.：1034616-18-6
Product Details -
-
-
-
-
-
Rigosertib
Cat. No.：BCP08296
No.：592542-59-1
Product Details
Tags:TAK-960 hydrochloride supplier,TAK-960 hydrochloride purchase,TAK-960 hydrochloride manufacturer,TAK-960 hydrochloride distributor,TAK-960 hydrochloride cost,TAK-960 hydrochloride buy,TAK-960 hydrochloride for sale